Confluent Executive and Leadership Team

Dean Schauer, the President & Chief Executive Officer at Confluent, directs the company's overarching strategy and market positioning. Schauer guides Confluent's application of materials science to MedTech innovation, ensuring the development of engineered solutions for challenging design problems. This leadership role involves fostering partnerships with leading OEMs to create a selective product portfolio, including complex applications like transcatheter heart valves and neurovascular implants. Overseeing all aspects of the business, Dean Schauer drives the company's mission to enable customers to offer life-saving products. The executive's focus remains on leveraging proprietary expertise in Nitinol processing, biomedical textiles, and precision laser treatment of specialty polymers to maintain Confluent's competitive edge and expand its influence within the medical device community. Schauer's strategic vision ensures sustained growth and market leadership across all operational geographies.

Matthew Eckl, the Chief Financial Officer at Confluent, manages all financial operations and strategic financial planning. Eckl oversees the fiscal health of the organization, ensuring robust financial controls and driving profitability across Confluent's diverse manufacturing facilities in the United States and Costa Rica. This executive's responsibilities include capital allocation, investment strategy, and financial reporting, directly supporting the company's growth initiatives in MedTech innovation. Matthew Eckl works closely with other C-suite leaders to align financial objectives with operational execution, particularly in the development of life-saving medical devices. The Chief Financial Officer's expertise is critical in navigating market dynamics and securing resources for the advancement of proprietary materials science and manufacturing processes. Eckl's financial acumen underpins the company's ability to invest in cutting-edge technologies and maintain its reputation for engineering excellence.

Edward Pike, the Chief Operating Officer at Confluent, directs the company's global manufacturing and operational efficiency. Pike oversees the complex production processes involving high purity Nitinol, ultra-high density knitting of biomedical textiles, and precision laser treatment of specialty polymers across Confluent's multiple facilities. This leadership position is vital for ensuring the consistent delivery of high-quality, engineered solutions that enable OEM medical device customers to launch life-saving products. Edward Pike collaborates with engineering and supply chain teams to optimize manufacturing workflows and maintain stringent quality standards, critical for demanding applications like transcatheter heart valves and neurovascular implants. The Chief Operating Officer's operational oversight ensures that Confluent's materials science and manufacturing expertise translate into tangible value for clients. Pike's strategic management of operations supports the company's expansion and its proven track record in the medical device community.

John Gray, the President at Confluent, drives strategic initiatives and market expansion for the company's MedTech innovations. Gray focuses on strengthening Confluent's relationships with leading OEMs, ensuring the seamless integration of advanced materials science and manufacturing expertise into their product portfolios. This role involves overseeing the development and commercialization of complex medical devices, including endovascular stent grafts and advanced smart catheters, leveraging Confluent's proprietary capabilities. John Gray works to enhance the company's market presence and operational reach across its various domestic and international locations. The President's leadership ensures that Confluent continues to be a trusted partner for customers seeking solutions to the most challenging design problems in the medical device sector. Gray's strategic direction supports the company's commitment to innovation and its role in enabling life-saving technologies.